Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $141.7200 (0.36%) ($141.2900 - $145.5400) on Tue. Sep. 27, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.23% (three month average) | RSI | 58 | Latest Price | $141.7200(0.36%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 0.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(28%) DIA(23%) SPLV(22%) XLP(21%) VYM(20%) | Factors Impacting ABBV price | ABBV will decline at least -0.615% in a week (0% probabilities). UUP(-14%) VIXM(-13%) EDOC(-9%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.615% (StdDev 1.23%) | Hourly BBV | -0.2 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $141.86(-0.1%) | 10 Day Moving Average | $141.99(-0.19%) | 20 Day Moving Average | $140.31(1%) | To recent high | -8.1% | To recent low | 5.4% | Market Cap | $250.034b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |